J.A. Jakubowski

1.6k total citations
32 papers, 1.3k citations indexed

About

J.A. Jakubowski is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Pharmacology. According to data from OpenAlex, J.A. Jakubowski has authored 32 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 10 papers in Hematology and 8 papers in Pharmacology. Recurrent topics in J.A. Jakubowski's work include Antiplatelet Therapy and Cardiovascular Diseases (12 papers), Platelet Disorders and Treatments (10 papers) and Eicosanoids and Hypertension Pharmacology (8 papers). J.A. Jakubowski is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (12 papers), Platelet Disorders and Treatments (10 papers) and Eicosanoids and Hypertension Pharmacology (8 papers). J.A. Jakubowski collaborates with scholars based in United States, Australia and Japan. J.A. Jakubowski's co-authors include Thompson Cb, C. Mildred Thompson, Daniel Deykin, Belay Tesfamariam, Richard A. Cohen, N.G. Ardlie, R. Vaillancourt, C. R. Valeri, P. Quinn and Ruth M. Kramer and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Blood.

In The Last Decade

J.A. Jakubowski

31 papers receiving 1.2k citations

Peers

J.A. Jakubowski
L B Safier United States
P.D. Winocour Canada
Andria D’Orazio Italy
N Islam United States
Giuseppe G. Nenci Italy
Akira Shouzu Japan
Keiji Takazoe Japan
K.A. Mitropoulos United Kingdom
Lenore B. Safier United States
J C Hoak United States
L B Safier United States
J.A. Jakubowski
Citations per year, relative to J.A. Jakubowski J.A. Jakubowski (= 1×) peers L B Safier

Countries citing papers authored by J.A. Jakubowski

Since Specialization
Citations

This map shows the geographic impact of J.A. Jakubowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.A. Jakubowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.A. Jakubowski more than expected).

Fields of papers citing papers by J.A. Jakubowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.A. Jakubowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.A. Jakubowski. The network helps show where J.A. Jakubowski may publish in the future.

Co-authorship network of co-authors of J.A. Jakubowski

This figure shows the co-authorship network connecting the top 25 collaborators of J.A. Jakubowski. A scholar is included among the top collaborators of J.A. Jakubowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.A. Jakubowski. J.A. Jakubowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sugidachi, Atsuhiro, et al.. (2013). A comparison of the pharmacological profiles of prasugrel and ticagrelor assessed by platelet aggregation, thrombus formation and haemostasis in rats. British Journal of Pharmacology. 169(1). 82–89. 28 indexed citations
2.
Trenk, Dietmar, et al.. (2012). A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity. 59(24). 32 indexed citations
3.
Frelinger, Andrew L., J.A. Jakubowski, M.R. BARNARD, et al.. (2007). The active metabolite of prasugrel inhibits ADP-stimulated thrombo-inflammatory markers of platelet activation: Influence of other blood cells, calcium, and aspirin. Journal of Thrombosis and Haemostasis. 98(1). 192–200. 5 indexed citations
4.
Dubé, Gregory P., et al.. (1992). In vitro characterization of a novel TXA2/PGH2 receptor ligand (S-145) in platelets and vascular and airway smooth muscle.. Journal of Pharmacology and Experimental Therapeutics. 262(2). 784–791. 8 indexed citations
5.
Jackson, Charles V., et al.. (1992). Pharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosis.. Journal of Pharmacology and Experimental Therapeutics. 261(2). 546–552. 22 indexed citations
6.
Hardinger, Steven A., J.A. Jakubowski, & P. L. Fuchs. (1991). Triply-convergent syntheses of two homochiral arene-fused prostacyclin analogs related to U68,215. Bioorganic & Medicinal Chemistry Letters. 1(1). 79–82. 8 indexed citations
7.
BRAISH, T. F., et al.. (1991). Triply-convergent synthesis of a homochiral 3,3-dimethyl, 15-cyclohexyl prostacyclin analog. Bioorganic & Medicinal Chemistry Letters. 1(11). 649–652. 5 indexed citations
8.
MOHAMADI, F., et al.. (1991). Thromboxane A2 receptor antagonists. Synthesis and activities of phenylsulfonamido derivatives. European Journal of Medicinal Chemistry. 26(8). 821–827. 6 indexed citations
9.
Brown, Michael L., et al.. (1988). Elevated glucose alters eicosanoid release from porcine aortic endothelial cells.. Journal of Clinical Investigation. 82(6). 2136–2141. 40 indexed citations
10.
Rocklin, Ross E., et al.. (1988). Altered arachidonic acid metabolism and platelet size in atopic subjects. Clinical Immunology and Immunopathology. 46(3). 352–359. 21 indexed citations
11.
Cb, Thompson & J.A. Jakubowski. (1988). The pathophysiology and clinical relevance of platelet heterogeneity. Blood. 72(1). 1–8. 178 indexed citations
12.
13.
Jakubowski, J.A., Harry L. Bush, R. Vaillancourt, & Daniel Deykin. (1987). Effect of chronic low dose aspirin on platelet and vascular eicosanoid metabolism in nonhuman primates (Macaca fascicularis).. Arteriosclerosis An Official Journal of the American Heart Association Inc. 7(6). 599–604. 8 indexed citations
14.
Jakubowski, J.A., et al.. (1985). Acute postprandial lipaemia does not influence the activity of human platelets. Thrombosis Research. 39(6). 725–732. 20 indexed citations
15.
Thompson, C. Mildred, et al.. (1984). Platelet size and age determine platelet function independently. Blood. 63(6). 1372–1375. 16 indexed citations
16.
Kramer, Ruth M., J.A. Jakubowski, R. Vaillancourt, & Daniel Deykin. (1982). Effect of membrane cholesterol on phospholipid metabolism in thrombin-stimulated platelets. Enhanced activation of platelet phospholipase(s) for liberation of arachidonic acid.. Journal of Biological Chemistry. 257(12). 6844–6849. 74 indexed citations
17.
Jakubowski, J.A., N.G. Ardlie, & Paul J. Nestel. (1980). The effect of hypercholesterolaemia on the lipid composition and ability of human platelets to accumulate cyclic AMP. Prostaglandins and Medicine. 5(6). 457–467. 19 indexed citations
18.
19.
Jakubowski, J.A. & N.G. Ardlie. (1978). Modification of human platelet function by a diet enriched in saturated or polyunsaturated fat. Atherosclerosis. 31(3). 335–344. 53 indexed citations
20.
Jakubowski, J.A., et al.. (1971). [Synthesis of 2-chloro-4-(beta-phenylethylamino)-pyrimidine].. PubMed. 28(1). 1–3.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L B Safier Breakdown of academic impact, for papers by P.D. Winocour Breakdown of academic impact, for papers by Andria D’Orazio Breakdown of academic impact, for papers by N Islam Breakdown of academic impact, for papers by Giuseppe G. Nenci Breakdown of academic impact, for papers by Akira Shouzu Breakdown of academic impact, for papers by Keiji Takazoe Breakdown of academic impact, for papers by K.A. Mitropoulos Breakdown of academic impact, for papers by Lenore B. Safier Breakdown of academic impact, for papers by J C Hoak
Rankless by CCL
2026